Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 92

1.

Perspectives in melanoma: Meeting report from the Melanoma Bridge (30 November-2 December, 2017, Naples, Italy).

Ascierto PA, Puzanov I, Agarwala SS, Bifulco C, Botti G, Caracò C, Ciliberto G, Davies MA, Dummer R, Ferrone S, Gajewski TF, Garbe C, Luke JJ, Marincola FM, Masucci G, Mehnert JM, Mozzillo N, Palmieri G, Postow MA, Schoenberger SP, Wang E, Thurin M.

J Transl Med. 2018 Jul 21;16(1):207. doi: 10.1186/s12967-018-1568-6.

2.

Is It Possible to Develop Cancer Vaccines to Neoantigens, What Are the Major Challenges, and How Can These Be Overcome? Targeting the Right Antigens in the Right Patients.

Schoenberger SP.

Cold Spring Harb Perspect Biol. 2017 Dec 18. pii: a028837. doi: 10.1101/cshperspect.a028837. [Epub ahead of print]

PMID:
29254974
3.

T cells control the generation of nanomolar-affinity anti-glycan antibodies.

Polonskaya Z, Deng S, Sarkar A, Kain L, Comellas-Aragones M, McKay CS, Kaczanowska K, Holt M, McBride R, Palomo V, Self KM, Taylor S, Irimia A, Mehta SR, Dan JM, Brigger M, Crotty S, Schoenberger SP, Paulson JC, Wilson IA, Savage PB, Finn MG, Teyton L.

J Clin Invest. 2017 Apr 3;127(4):1491-1504. doi: 10.1172/JCI91192. Epub 2017 Mar 13.

4.

1st International Conference on Human &Translational Immunology.

Hope JL, Pulendran B, Schoenberger SP, Katsikis PD.

Nat Immunol. 2016 Dec 16;18(1):1-4. doi: 10.1038/ni.3635.

PMID:
27984565
5.

Erratum: Mutant MHC class II epitopes drive therapeutic immune responses to cancer.

Kreiter S, Vormehr M, van de Roemer N, Diken M, Löwer M, Diekmann J, Boegel S, Schrörs B, Vascotto F, Castle JC, Tadmor AD, Schoenberger SP, Huber C, Türeci Ö, Sahin U.

Nature. 2015 Jul 16;523(7560):370. doi: 10.1038/nature14567. Epub 2015 Jun 3. No abstract available.

PMID:
26040715
6.

Mutant MHC class II epitopes drive therapeutic immune responses to cancer.

Kreiter S, Vormehr M, van de Roemer N, Diken M, Löwer M, Diekmann J, Boegel S, Schrörs B, Vascotto F, Castle JC, Tadmor AD, Schoenberger SP, Huber C, Türeci Ö, Sahin U.

Nature. 2015 Apr 30;520(7549):692-6. doi: 10.1038/nature14426. Epub 2015 Apr 22. Erratum in: Nature. 2015 Jul 16;523(7560):370.

7.

CD28 Promotes Plasma Cell Survival, Sustained Antibody Responses, and BLIMP-1 Upregulation through Its Distal PYAP Proline Motif.

Rozanski CH, Utley A, Carlson LM, Farren MR, Murray M, Russell LM, Nair JR, Yang Z, Brady W, Garrett-Sinha LA, Schoenberger SP, Green JM, Boise LH, Lee KP.

J Immunol. 2015 May 15;194(10):4717-28. doi: 10.4049/jimmunol.1402260. Epub 2015 Apr 1.

8.

Notch signaling maintains T cell memories.

Miller AM, Schoenberger SP.

Nat Med. 2015 Jan;21(1):16-8. doi: 10.1038/nm.3784. No abstract available.

PMID:
25569546
9.

FoxO3 is a negative regulator of primary CD8+ T-cell expansion but not of memory formation.

Togher S, Larange A, Schoenberger SP, Feau S.

Immunol Cell Biol. 2015 Feb;93(2):120-5. doi: 10.1038/icb.2014.78. Epub 2014 Sep 23.

10.

Unique lamina propria stromal cells imprint the functional phenotype of mucosal dendritic cells.

Vicente-Suarez I, Larange A, Reardon C, Matho M, Feau S, Chodaczek G, Park Y, Obata Y, Gold R, Wang-Zhu Y, Lena C, Zajonc DM, Schoenberger SP, Kronenberg M, Cheroutre H.

Mucosal Immunol. 2015 Jan;8(1):141-51. doi: 10.1038/mi.2014.51. Epub 2014 Jun 18.

11.

T cell exhaustion: a means or an end?

Salek-Ardakani S, Schoenberger SP.

Nat Immunol. 2013 Jun;14(6):531-3. doi: 10.1038/ni.2619. No abstract available.

PMID:
23685816
12.

Invariant NKT cells induce plasmacytoid dendritic cell (DC) cross-talk with conventional DCs for efficient memory CD8+ T cell induction.

Shimizu K, Asakura M, Shinga J, Sato Y, Kitahara S, Hoshino K, Kaisho T, Schoenberger SP, Ezaki T, Fujii S.

J Immunol. 2013 Jun 1;190(11):5609-19. doi: 10.4049/jimmunol.1300033. Epub 2013 Apr 29.

13.

SLAT regulates CD8+ T cell clonal expansion in a Cdc42- and NFAT1-dependent manner.

Feau S, Schoenberger SP, Altman A, Bécart S.

J Immunol. 2013 Jan 1;190(1):174-83. doi: 10.4049/jimmunol.1201685. Epub 2012 Nov 28.

14.

Polyfunctional CD4+ T cell responses to immunodominant epitopes correlate with disease activity of virulent Salmonella.

Maybeno M, Redeker A, Welten SP, Peters B, Loughhead SM, Schoenberger SP, Sette A, Arens R.

PLoS One. 2012;7(8):e43481. doi: 10.1371/journal.pone.0043481. Epub 2012 Aug 17.

15.

The CD4⁺ T-cell help signal is transmitted from APC to CD8⁺ T-cells via CD27-CD70 interactions.

Feau S, Garcia Z, Arens R, Yagita H, Borst J, Schoenberger SP.

Nat Commun. 2012 Jul 10;3:948. doi: 10.1038/ncomms1948.

16.

CD69 guides CD4+ T cells to the seat of memory.

Schoenberger SP.

Proc Natl Acad Sci U S A. 2012 May 29;109(22):8358-9. doi: 10.1073/pnas.1204616109. Epub 2012 May 21. No abstract available.

17.

4th Aegean Conference on the Crossroads between Innate and Adaptive Immunity.

Schoenberger SP, Pulendran B, Katsikis PD.

Nat Immunol. 2011 Dec 16;13(1):7-10. doi: 10.1038/ni.2192. No abstract available.

PMID:
22179270
18.

Nab2 regulates secondary CD8+ T-cell responses through control of TRAIL expression.

Wolkers MC, Gerlach C, Arens R, Janssen EM, Fitzgerald P, Schumacher TN, Medema JP, Green DR, Schoenberger SP.

Blood. 2012 Jan 19;119(3):798-804. doi: 10.1182/blood-2011-08-373910. Epub 2011 Nov 29.

19.

Mucosal memory CD8⁺ T cells are selected in the periphery by an MHC class I molecule.

Huang Y, Park Y, Wang-Zhu Y, Larange A, Arens R, Bernardo I, Olivares-Villagómez D, Herndler-Brandstetter D, Abraham N, Grubeck-Loebenstein B, Schoenberger SP, Van Kaer L, Kronenberg M, Teitell MA, Cheroutre H.

Nat Immunol. 2011 Oct 2;12(11):1086-95. doi: 10.1038/ni.2106.

20.

Autocrine IL-2 is required for secondary population expansion of CD8(+) memory T cells.

Feau S, Arens R, Togher S, Schoenberger SP.

Nat Immunol. 2011 Jul 31;12(9):908-13. doi: 10.1038/ni.2079.

21.

Immune adjuvant efficacy of CpG oligonucleotide in cancer treatment is founded specifically upon TLR9 function in plasmacytoid dendritic cells.

Nierkens S, den Brok MH, Garcia Z, Togher S, Wagenaars J, Wassink M, Boon L, Ruers TJ, Figdor CG, Schoenberger SP, Adema GJ, Janssen EM.

Cancer Res. 2011 Oct 15;71(20):6428-37. doi: 10.1158/0008-5472.CAN-11-2154. Epub 2011 Jul 25.

22.

Sustained antibody responses depend on CD28 function in bone marrow-resident plasma cells.

Rozanski CH, Arens R, Carlson LM, Nair J, Boise LH, Chanan-Khan AA, Schoenberger SP, Lee KP.

J Exp Med. 2011 Jul 4;208(7):1435-46. doi: 10.1084/jem.20110040. Epub 2011 Jun 20.

23.

Interleukin-2 rescues helpless effector CD8+ T cells by diminishing the susceptibility to TRAIL mediated death.

Wolkers MC, Bensinger SJ, Green DR, Schoenberger SP, Janssen EM.

Immunol Lett. 2011 Sep 30;139(1-2):25-32. doi: 10.1016/j.imlet.2011.04.011. Epub 2011 May 20.

24.

Differential B7-CD28 costimulatory requirements for stable and inflationary mouse cytomegalovirus-specific memory CD8 T cell populations.

Arens R, Loewendorf A, Redeker A, Sierro S, Boon L, Klenerman P, Benedict CA, Schoenberger SP.

J Immunol. 2011 Apr 1;186(7):3874-81. doi: 10.4049/jimmunol.1003231. Epub 2011 Feb 28.

25.

From the loading dock to the boardroom: a new job for Akt kinase.

Feau S, Schoenberger SP.

Immunity. 2011 Feb 25;34(2):141-3. doi: 10.1016/j.immuni.2011.02.013.

26.

The TNFR family members OX40 and CD27 link viral virulence to protective T cell vaccines in mice.

Salek-Ardakani S, Flynn R, Arens R, Yagita H, Smith GL, Borst J, Schoenberger SP, Croft M.

J Clin Invest. 2011 Jan;121(1):296-307. doi: 10.1172/JCI42056. Epub 2010 Dec 22.

27.

Enhancement of proliferation and downregulation of TRAIL expression on CD8+ T cells by IL-21.

Melief CJ, Schoenberger SP.

Eur J Immunol. 2010 Nov;40(11):2990-2. doi: 10.1002/eji.201041076. Review.

28.

B7-mediated costimulation of CD4 T cells constrains cytomegalovirus persistence.

Arens R, Loewendorf A, Her MJ, Schneider-Ohrum K, Shellam GR, Janssen E, Ware CF, Schoenberger SP, Benedict CA.

J Virol. 2011 Jan;85(1):390-6. doi: 10.1128/JVI.01839-10. Epub 2010 Oct 27.

29.

TRAIL-expressing CD8+ T cells mediate tolerance following soluble peptide-induced peripheral T cell deletion.

Gurung P, Kucaba TA, Schoenberger SP, Ferguson TA, Griffith TS.

J Leukoc Biol. 2010 Dec;88(6):1217-25. doi: 10.1189/jlb.0610343. Epub 2010 Aug 31.

30.

Memory T Cells. Preface.

Zanetti M, Schoenberger SP.

Adv Exp Med Biol. 2010;684:vii-ix. No abstract available.

PMID:
20795535
31.

Separate roles for antigen recognition and lymph node inflammation in CD8+ memory T cell formation.

Fransen MF, van Stipdonk MJ, Sluijter M, Schoenberger SP, Melief CJ, Offringa R.

J Immunol. 2010 Sep 15;185(6):3167-73. doi: 10.4049/jimmunol.0904046. Epub 2010 Aug 9.

32.

Plasticity in programming of effector and memory CD8 T-cell formation.

Arens R, Schoenberger SP.

Immunol Rev. 2010 May;235(1):190-205. doi: 10.1111/j.0105-2896.2010.00899.x. Review.

33.

The 2010 Midwinter Conference of Immunologists at Asilomar.

Schoenberger SP, Cheroutre H, Uittenbogaart C, Marshak-Rothstein A.

Nat Immunol. 2010 May;11(5):359-61. doi: 10.1038/ni0510-359. No abstract available.

PMID:
20404845
34.

Distinct roles of cytolytic effector molecules for antigen-restricted killing by CTL in vivo.

Janssen EM, Lemmens EE, Gour N, Reboulet RA, Green DR, Schoenberger SP, Pinkoski MJ.

Immunol Cell Biol. 2010 Oct;88(7):761-5. doi: 10.1038/icb.2010.37. Epub 2010 Mar 23.

35.

Effectors and memories: Bcl-6 and Blimp-1 in T and B lymphocyte differentiation.

Crotty S, Johnston RJ, Schoenberger SP.

Nat Immunol. 2010 Feb;11(2):114-20. doi: 10.1038/ni.1837. Epub 2010 Jan 19. Review.

36.

Tumor immunotherapy: making an immortal army.

Koehn BH, Schoenberger SP.

Nat Med. 2009 Jul;15(7):731-2. doi: 10.1038/nm0709-731. No abstract available.

37.

T cell memory.

Schoenberger SP.

Semin Immunol. 2009 Apr;21(2):51-2. doi: 10.1016/j.smim.2009.02.007. No abstract available.

38.

Preferential use of B7.2 and not B7.1 in priming of vaccinia virus-specific CD8 T cells.

Salek-Ardakani S, Arens R, Flynn R, Sette A, Schoenberger SP, Croft M.

J Immunol. 2009 Mar 1;182(5):2909-18. doi: 10.4049/jimmunol.0803545.

39.

Immunology. Ex uno plura.

Feau S, Schoenberger SP.

Science. 2009 Jan 23;323(5913):466-7. doi: 10.1126/science.1169409. No abstract available. Erratum in: Science. 2009 May 1;324(5927):592.

40.

The TRAIL of helpless CD8+ T cells in HIV infection.

Kuerten S, Asaad RJ, Schoenberger SP, Angelov DN, Lehmann PV, Tary-Lehmann M.

AIDS Res Hum Retroviruses. 2008 Sep;24(9):1175-83. doi: 10.1089/aid.2008.0062.

41.

Cutting edge: murine cytomegalovirus induces a polyfunctional CD4 T cell response.

Arens R, Wang P, Sidney J, Loewendorf A, Sette A, Schoenberger SP, Peters B, Benedict CA.

J Immunol. 2008 May 15;180(10):6472-6.

42.

Probing the 'labyrinth' linking the innate and adaptive immune systems.

Katsikis PD, Schoenberger SP, Pulendran B.

Nat Immunol. 2007 Sep;8(9):899-901. No abstract available.

PMID:
17712338
43.

Paradoxical effect of reduced costimulation in T cell-mediated colitis.

Kim G, Levin M, Schoenberger SP, Sharpe A, Kronenberg M.

J Immunol. 2007 May 1;178(9):5563-70.

44.

Synergistic costimulation by both B7 molecules regulates colitis pathogenesis.

Kim G, Schoenberger SP, Sharpe A, Kronenberg M.

Ann N Y Acad Sci. 2006 Aug;1072:233-41. Review.

PMID:
17057203
45.

Cytosolic entry controls CD8+-T-cell potency during bacterial infection.

Bahjat KS, Liu W, Lemmens EE, Schoenberger SP, Portnoy DA, Dubensky TW Jr, Brockstedt DG.

Infect Immun. 2006 Nov;74(11):6387-97. Epub 2006 Sep 5.

46.

IL-2 gets with the program.

Schoenberger SP, Janssen EM.

Nat Immunol. 2006 Aug;7(8):798-800. No abstract available.

PMID:
16855604
47.

Duration of CTL activation regulates IL-2 production required for autonomous clonal expansion.

Spierings DC, Lemmens EE, Grewal K, Schoenberger SP, Green DR.

Eur J Immunol. 2006 Jul;36(7):1707-17.

48.

Efficient T cell activation via a Toll-Interleukin 1 Receptor-independent pathway.

Janssen E, Tabeta K, Barnes MJ, Rutschmann S, McBride S, Bahjat KS, Schoenberger SP, Theofilopoulos AN, Beutler B, Hoebe K.

Immunity. 2006 Jun;24(6):787-99.

49.

The generation of protective memory-like CD8+ T cells during homeostatic proliferation requires CD4+ T cells.

Hamilton SE, Wolkers MC, Schoenberger SP, Jameson SC.

Nat Immunol. 2006 May;7(5):475-81. Epub 2006 Apr 9.

PMID:
16604076
50.

Lipid raft targeting of hematopoietic protein tyrosine phosphatase by protein kinase C theta-mediated phosphorylation.

Nika K, Charvet C, Williams S, Tautz L, Bruckner S, Rahmouni S, Bottini N, Schoenberger SP, Baier G, Altman A, Mustelin T.

Mol Cell Biol. 2006 Mar;26(5):1806-16.

Supplemental Content

Loading ...
Support Center